Semaglutide – Long-Acting GLP-1 Analogue for Research
Semaglutide is an advanced synthetic peptide analogue of human glucagon-like peptide-1, commonly known as GLP-1. Its specialised molecular structure supports selective GLP-1 receptor activation, improved enzymatic stability and an extended research profile.
With 94% sequence homology to naturally occurring human GLP-1, Semaglutide is particularly relevant for professional laboratory studies involving incretin signalling, receptor pharmacology, glucose-dependent pathways, metabolic communication and long-acting peptide development.
Semaglutide is supplied as a lyophilised research material in a securely sealed vial with clear batch-specific product information and professional packaging.
Caratteristiche principali del prodotto
- Synthetic GLP-1 peptide analogue
- 94% sequence homology to human GLP-1
- Selective GLP-1 receptor activity
- Long-acting lipidated molecular structure
- Progettato per favorire il legame con l'albumina
- Relevant for incretin-signalling research
- Suitable for receptor and metabolic pathway studies
- Fornito come materiale di ricerca liofilizzato
- Informazioni chiare sul prodotto specifiche per lotto
- Imballaggio sicuro e discreto
What Is Semaglutide?
Semaglutide is a modified analogue of naturally occurring GLP-1, a peptide hormone produced in the gastrointestinal system following nutrient intake.
Native GLP-1 participates in communication between the digestive system, pancreas and central nervous system. It is studied for its involvement in glucose-dependent pancreatic signalling, glucagon-related pathways, gastric-emptying mechanisms and appetite-related neuroendocrine communication.
Natural GLP-1 is rapidly broken down by the enzyme dipeptidyl peptidase-4, also known as DPP-4. Semaglutide contains structural modifications designed to increase resistance to enzymatic degradation and extend molecular exposure.
Ricerca sul recettore GLP-1
Semaglutide selectively binds to and activates the GLP-1 receptor, a G-protein-coupled receptor expressed in multiple tissues.
Potential areas of laboratory investigation include:
- GLP-1 receptor binding
- Selective receptor activation
- Interazioni ligando-recettore
- Segnalazione dell'AMP ciclico
- Trasduzione del segnale intracellulare
- Internalizzazione del recettore
- Relazioni concentrazione-risposta
- Sensibilità del recettore
- Ricerca comparativa sugli analoghi del GLP-1
- Farmacologia dei recettori delle incretine
The exact experimental concentrations, controls and analytical methods should be established by the qualified laboratory conducting the research.
Progettazione molecolare avanzata
Semaglutide contains several structural modifications that distinguish it from native GLP-1.
Its molecular design includes:
- A peptide backbone closely related to human GLP-1
- 94% sequence homology with native human GLP-1
- Amino-acid modifications that support DPP-4 resistance
- A fatty-diacid side chain
- Proprietà reversibili di legame con l'albumina
- Improved molecular stability
- Riduzione della rapida eliminazione
- An extended pharmacokinetic research profile
Albumin binding is widely studied as a method for prolonging peptide exposure and improving the stability of peptide-based compounds.
Incretin-Signalling Research
GLP-1 is part of the incretin hormone system. Incretin hormones are released in response to nutrients and participate in communication between the gastrointestinal tract, pancreas and other tissues.
Semaglutide may be relevant for laboratory studies examining:
- Nutrient-responsive signalling
- Pancreatic cell communication
- Glucose-dependent insulin-signalling pathways
- Glucagon-related mechanisms
- Postprandial metabolic responses
- Incretin-hormone activity
- Comunicazione gastrointestinale-pancreatica
- Farmacologia comparata delle incretine
- Metabolic biomarker analysis
These areas describe scientific pathways and do not represent claims regarding the use of this research product as a treatment.
Ricerca sulle vie metaboliche
Semaglutide is widely studied in relation to metabolic and neuroendocrine signalling.
Potential research areas include:
- Vie metaboliche dell'omeostasi del glucosio
- Segnalazione del bilancio energetico
- Appetite-related neural pathways
- Segnalazione legata alla sazietà
- Gastric-emptying mechanisms
- Pancreatic hormone interactions
- Nutrient utilisation
- Metabolic gene expression
- Cellular energy regulation
- Comunicazione neuroendocrina
- Comparative metabolic models
Research findings from authorised pharmaceutical products should not automatically be applied to a non-pharmaceutical research material.
Long-Acting Peptide Research
The lipidated design of Semaglutide makes it relevant for research into techniques used to extend peptide stability and molecular duration.
Potential areas of investigation include:
- Lipidizzazione dei peptidi
- tecnologia di legame dell'albumina
- resistenza enzimatica
- Estensione dell'emivita molecolare
- Peptide-clearance mechanisms
- Ottimizzazione farmacocinetica
- Attivazione del recettore di lunga durata
- Relazioni struttura-attività
- Modified peptide analogues
- Ingegneria dei peptidi a lunga durata d'azione
Researchers may compare Semaglutide with native GLP-1, shorter-acting GLP-1 analogues or other incretin-related compounds.
Potenziali applicazioni di ricerca
Semaglutide may be relevant for controlled scientific studies involving:
- Farmacologia del recettore GLP-1
- Incretin-hormone signalling
- Pancreatic cell models
- Vie metaboliche dipendenti dal glucosio
- Glucagon-related signalling
- Appetite and satiety pathways
- Gastric-emptying research
- meccanismi di bilancio energetico
- Albumin-binding studies
- Peptide-stability analysis
- Sviluppo di peptidi a lunga durata d'azione
- Comparative receptor research
- Caratterizzazione analitica dei peptidi
- Analisi cromatografica
- Analisi mediante spettrometria di massa
- Test di stabilità e degradazione
Specifiche del prodotto
| Caratteristiche del prodotto |
Informazioni |
| Nome del prodotto |
Semaglutide |
| Categoria di prodotto |
Peptide sintetico per la ricerca |
| Tipo composto |
Long-acting GLP-1 analogue |
| Sequence similarity |
94% homology to human GLP-1 |
| Obiettivo primario della ricerca |
GLP-1 receptor |
| Modificazione molecolare |
Lipidated peptide with fatty-diacid side chain |
| Key property |
Reversible albumin binding |
| Modulo |
Polvere liofilizzata |
| Presentazione |
Fiala da ricerca sigillata in modo sicuro |
| Documentazione |
Informazioni analitiche specifiche per lotto |
| Confezione |
Imballaggio sicuro e discreto |
| Applicazione prevista |
Ricerca scientifica, analitica e di laboratorio |
Formato di ricerca liofilizzato
Semaglutide is supplied as a lyophilised research material in a securely sealed vial.
Lyophilisation removes moisture and is commonly used to support peptide stability during controlled storage and transportation. Minor variations in appearance may occur because of production conditions, product quantity and residual moisture.
Physical appearance alone should not be used to determine product identity, purity or analytical quality. Researchers should review the applicable batch documentation before beginning laboratory work.
Qualità e trasparenza del prodotto
Peptides Divas focuses on clear product specifications, careful handling and batch-level traceability.
Available product documentation may include:
- Identificazione del prodotto
- Numero di lotto
- Purezza dichiarata
- Analisi HPLC
- Dati di spettrometria di massa
- Informazioni sui test
- Aspetto del prodotto
- Consigli per la conservazione
- Ulteriori osservazioni analitiche
Ciò fornisce ai ricercatori informazioni chiare e tracciabili relative al lotto di prodotto in questione.
Informazioni di archiviazione
Store Semaglutide in its original sealed packaging under the conditions stated on the product label and applicable batch documentation.
Protect the research material from:
- Luce solare diretta
- Calore eccessivo
- Umidità
- Contaminazione
- Imballaggio danneggiato
- Fluttuazioni ripetute della temperatura
- Esposizione non necessaria all'aria
Il laboratorio ricevente è responsabile della definizione e della convalida di procedure adeguate di preparazione, manipolazione e conservazione per il proprio specifico protocollo di ricerca.
Why Choose Semaglutide?
Semaglutide provides a well-characterised long-acting GLP-1 analogue for advanced receptor, metabolic and peptide-development research.
Key research advantages include:
- Selective GLP-1 receptor activity
- High sequence similarity to native human GLP-1
- Specialised albumin-binding molecular design
- Extended research profile
- Relevant for incretin-signalling studies
- Suitable for comparative receptor analysis
- Useful for long-acting peptide research
- Informazioni chiare sul prodotto specifiche per lotto
Perché ordinare da Peptides Divas?
Peptides Divas unisce un catalogo di ricerca accuratamente selezionato a un servizio rapido e professionale. I clienti beneficiano di:
- Specifiche chiare del prodotto
- Informazioni analitiche specifiche per lotto
- Elaborazione rapida degli ordini
- Imballaggio sicuro e discreto
- Opzioni di spedizione tracciabili
- Maneggiare il prodotto con cura
- Assistenza clienti reattiva
- Consegna affidabile in Europa
Choose Semaglutide from Peptides Divas for advanced laboratory research involving GLP-1 receptor activity, incretin signalling, metabolic pathways and long-acting peptide development.
For laboratory research use only. Not intended for human or veterinary use.
